- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 72.56M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $72K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $318K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $735K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $1.74M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $915K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.31M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $9.26M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $16.64M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $14.64M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $4M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.28M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $8.98M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.63M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.44M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$983K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$12.41M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$599K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$0.36 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.36 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11.74M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.56M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.84M |